Management Plan for Type 2 Diabetes with Peripheral Neuropathy and Foot Ulcer
This patient requires immediate intensification of diabetes management with a target A1C <8%, aggressive foot ulcer care with integrated multidisciplinary follow-up every 1-3 months, optimization of blood pressure control, and initiation of neuropathic pain treatment with duloxetine or pregabalin as first-line therapy.
Immediate Glycemic Management
Intensify diabetes therapy immediately - the current A1C of 9.2% on metformin 500 mg BID alone is inadequate and directly contributes to neuropathy progression and impaired ulcer healing 1.
- Add a GLP-1 receptor agonist (semaglutide or liraglutide) - these agents reduce cardiovascular events in patients with diabetes and PAD, with hazard ratios of 0.74-0.87 for MACE 2
- Alternative: Add an SGLT-2 inhibitor (empagliflozin, dapagliflozin, or canagliflozin) - particularly beneficial if heart failure is present, with proven MACE reduction in PAD patients 2
- Increase metformin to 1000 mg BID if tolerated
- Target A1C <8% (not <7%) given the established complications - overly aggressive targets increase hypoglycemia risk without additional benefit in this population 3
- Consider basal insulin if A1C remains >8% after 3 months despite dual therapy
The evidence strongly supports intensive glycemic control to slow neuropathy progression in type 2 diabetes, though it won't reverse existing nerve damage 3, 4.
Blood Pressure Optimization
Increase lisinopril from 10 mg to 20 mg daily - current BP of 146/88 mmHg is above target. Optimal blood pressure control reduces neuropathy risk and progression 3. Target BP <140/90 mmHg, or <130/80 mmHg if tolerated without adverse effects.
Foot Ulcer Management - Critical Priority
This patient is IWGDF Risk Category 3 (peripheral neuropathy + active ulcer), requiring the most intensive intervention 1.
Immediate Ulcer Care:
- Refer to podiatry or wound care specialist within 48 hours for professional debridement of the right foot ulcer 1
- Assess for infection - if present (erythema, warmth, purulence, or systemic signs), initiate broad-spectrum antibiotics covering polymicrobial organisms including MRSA and anaerobes 5
- Evaluate vascular status - check pedal pulses, consider ankle-brachial index to rule out peripheral artery disease that would impair healing 1, 2
- Offload the ulcer completely - prescribe total contact cast or removable cast walker (must be worn consistently) 1
Therapeutic Footwear:
Prescribe custom therapeutic footwear with demonstrated 30% plantar pressure reduction once the ulcer heals - this is a strong recommendation with moderate-quality evidence to prevent recurrence 1. The patient must wear this footwear both indoors and outdoors consistently.
Follow-up Schedule:
Schedule visits every 1-3 months for integrated foot care including professional foot treatment, footwear assessment, and education 1. This is non-negotiable for Risk Category 3 patients.
Neuropathic Pain Management
Initiate duloxetine 30 mg daily, titrate to 60 mg after one week for the burning pain (rated 6/10) 3, 4, 6. Duloxetine is FDA-approved for diabetic peripheral neuropathy and has the added benefit of not causing weight gain.
Alternative first-line options if duloxetine is contraindicated or not tolerated:
- Pregabalin 75 mg BID, titrate to 150-300 mg BID
- Gabapentin 300 mg daily, titrate to 900-3600 mg/day in divided doses
- Amitriptyline 25 mg at bedtime, titrate to 75-100 mg (avoid if cardiac conduction abnormalities)
Monitor response objectively at 4-6 weeks using a pain scale - if <30% pain reduction, switch to alternative first-line agent 4, 6. Avoid opioids except as last resort after failure of multiple first-line agents 4.
Structured Patient Education - Strong Recommendation
Provide immediate education on the following specific foot care practices 1:
Daily Self-Care (must do every day):
- Inspect feet and inside shoes daily for cuts, blisters, redness, or foreign objects
- Wash feet daily with lukewarm water, dry thoroughly especially between toes
- Apply emollient cream to dry skin (not between toes)
- Cut toenails straight across, file sharp edges
- Never walk barefoot, in socks only, or in thin slippers - indoors or outdoors
What to Avoid:
- Chemical corn removers or callus treatments
- Heating pads or hot water bottles on feet
- Tight socks or shoes
- Crossing legs for extended periods
When to Seek Immediate Care:
- Any new wound, blister, or redness
- Temperature difference between feet (>2.2°C suggests inflammation) 1
- Increased pain, swelling, or drainage from existing ulcer
Lifestyle Modifications
Prescribe specific dietary changes:
- Eliminate sugary drinks completely
- Replace processed foods with whole grains, vegetables, lean protein
- Target 500-750 calorie daily deficit for weight loss (current BMI 32.5)
- Refer to diabetes educator and dietitian for structured meal planning
Exercise prescription:
- Start with 10 minutes of non-weight-bearing exercise (swimming, cycling) daily
- Progress by 1000 steps/day increments as tolerated - this is safe for Risk Category 2-3 patients when wearing appropriate footwear and monitoring for lesions 1
- Avoid high-impact activities until ulcer heals
Diagnostic Testing
Order immediately:
- Complete metabolic panel (assess renal function given 8-year diabetes duration)
- Lipid panel (on atorvastatin but verify control)
- Vitamin B12 level (metformin can cause deficiency, worsening neuropathy) 4
- Wound culture if infection suspected
- Ankle-brachial index (ABI) to assess for PAD 7, 2
Consider if ABI abnormal:
- Vascular surgery referral for revascularization evaluation
Addressing Patient Concerns About Insulin
Explain that insulin may be necessary if oral agents and GLP-1/SGLT-2 inhibitors don't achieve A1C <8% within 3 months. Frame this as a tool to prevent blindness, kidney failure, and amputation rather than a sign of failure. Many patients eventually require insulin as beta-cell function declines - this is the natural progression of type 2 diabetes, not a personal failing.
Critical Pitfalls to Avoid
- Do not delay foot ulcer referral - every day increases infection and amputation risk
- Do not prescribe sliding-scale insulin alone - basal-bolus regimens are required if insulin is needed 7
- Do not ignore the small ulcer - 40% of diabetic foot ulcers recur within one year without proper prevention 1
- Do not assume the patient will comply with footwear - only 15-30% of patients wear prescribed footwear consistently; requires repeated reinforcement
- Do not use nerve decompression surgery - this is not recommended for ulcer prevention 1
Summary of Follow-up Schedule
- Week 1: Podiatry/wound care for ulcer assessment and debridement
- Week 2: Primary care follow-up to assess medication tolerance, review labs
- Week 4-6: Assess pain medication response, adjust if needed
- Month 3: Check A1C, adjust diabetes medications, foot examination
- Ongoing: Every 1-3 months for integrated foot care until ulcer heals, then every 3-6 months lifelong 1